mergers-and-acquisitions News
Semler Scientific Soars on $1.34B Bitcoin Merger Approval
Shareholders approve all-stock acquisition by Strive Inc., forging a new entity focused on a corporate Bitcoin treasury strategy.
U.S. Bancorp to Buy BTIG for Up to $1 Billion in Trading Push
Deal for the financial services firm marks a significant strategic expansion by the Minneapolis-based lender to build out its investment banking and capital markets capabilities.
Avadel Shares Rise as Shareholders Approve Alkermes Takeover
The shareholder vote clears a key hurdle for the $2.1 billion deal, bringing Avadel's narcolepsy drug LUMRYZ a step closer to Alkermes' portfolio.
Abivax Stock Soars on $17.5 Billion Eli Lilly Takeover Report
Shares in the French biotech surged after reports surfaced that the pharmaceutical giant is preparing a blockbuster bid for its promising ulcerative colitis drug.
Eli Lilly's M&A Focus Shifts, Cooling Rumors of $17.5B Abivax Bid
The pharmaceutical giant's recent deal for Ventyx Biosciences signals a potential strategic pivot, though its aggressive hunt for pipeline assets in the inflammatory disease space remains clear.
Edwards Lifesciences Halts JenaValve Merger After FTC Challenge
Shares hold steady as medtech giant abandons acquisition following a successful regulatory injunction, with analysts upgrading the stock on core business strength.
Haemonetics to Buy Vivasure for €100M, Bolstering Cardiac Surgery Tools
The acquisition adds a novel, fully absorbable vascular closure device, strengthening Haemonetics' position in the high-growth structural heart market.
Rio Tinto, Glencore in Talks for Mega-Merger to Forge Mining Titan
A deal would create a $260 billion-plus behemoth, combining Rio's iron ore dominance with Glencore's copper and trading might, but significant regulatory and strategic hurdles remain.